lar axis. In animals, digitalis directly sensitizes tonically active cardiopulmonary2'3 and arterial baroreceptors,4-6 potentiates cardiopulmonary baroreflex vagal afferents,7 and reflexly inhibits renal sympathetic nerve activity.8 Digitalis exerts central neural and efferent sympathoexcitatory actions in animals59-12 and direct constricting actions on vascular smooth muscle. [13] [14] [15] Limited studies in humans suggest that digitalis glycosides alter autonomic mechanisms, although the exact mechanisms remain unclear. Mason and Braunwald16 observed that ouabain produces forearm arterial and venous dilation in heart failure patients and vasoconstriction in normal humans. Prior studies in our laboratory using venous plethysmography to indirectly assess sympathetically mediated vascular responses confirmed these observations and suggested that digitalis glycosides potentiate cardiopulmonary baroreflex control of vascular resistance in heart failure patients. 17 Ferrari and colleagues18 have likewise demonstrated that digitalis augments the bradycardic and hypotensive responses to arterial baroreceptor activation in normotensive and hypertensive patients. More recently, studies from our laboratory have demonstrated an early and profound attenuation of efferent muscle sympathetic nerve activity (MSNA) in heart failure patients after administration of a rapidly acting digitalis preparation (Cedilanid-D) but no such sympathoinhibition after administration of equal inotropic doses of the nondigitalis inotropic agent dobutamine. 19 We hypothesized that this effect resulted from a direct sensitization of cardiopulmonary afferents by digitalis similar to that reported in animal models.
To assess more critically the autonomic actions of digitalis in humans and to define the mechanisms of these effects, we performed an entirely new series of studies in normal human subjects to test the hypothesis that acute administration of a digitalis glycoside would directly potentiate cardiopulmonary baroreflex control of efferent MSNA. We used percutaneous peroneal microneurography as a quantitative measurement of the neuroeffector limb during unloading of cardiopulmonary baroreceptors by lower body negative pressure (LBNP). To determine whether observed actions of digitalis were simply secondary to its inotropic action, we performed comparative studies with LBNP before and during administration of similar inotropic doses of dobutamine in a separate group of subjects.
Methods

Subjects
Twenty-two male subjects (age 22±t1 year, mean+SEM) were studied in three treatment groups: digitalis group (n=8; subjects 1-8), dobutamine group (n=8; subjects [9] [10] [11] [12] [13] [14] [15] [16] , and placebo group (n=6; subjects [17] [18] [19] [20] [21] [22] . All subjects were studied without sedation in the supine, postabsorptive state and were free of cardiovascular or other systemic diseases based on medical history and physical examination. Informed written consent was obtained before the study and the protocol was approved by the human subjects review committee of the University of Iowa.
Measurements
A direct writing, multichannel physiological recorder was used to-simultaneously record phasic and mean arterial and central venous pressures, heart rate, respiratory activity, forearm blood flow, level of LBNP, and MSNA.
Arterial pressure was measured directly through a 4Fr polyethylene arterial catheter inserted percutaneously in the right brachial artery. Mean arterial pressure was obtained by an electrical mean signal. Arterial pulse pressure was determined as systolic pressure minus diastolic pressure. Central venous pressure was measured through an 18.5 -gauge polyethylene catheter inserted percutaneously in a right median antecubital vein and advanced to an intrathoracic vein. Heart rate and rhythm were recorded continuously by electrocardiogram, and respiratory activity was recorded by a strain gauge pneumograph. Zero reference point for all hemodynamic measurements was defined at the phlebostatic axis in the midaxillary position.
Forearm blood flow was measured by venous occlusion plethysmography with a mercury-in-silastic Whitney strain gauge as previously described.17 '20'21 Blood flow was measured every 15 seconds, and the average value per minute was determined. Forearm vascular resistance was derived by dividing mean arterial pressure (mm Hg) by forearm blood flow (milliliters per minute per 100 ml of forearm volume) and expressed as units.
Microneurographic recordings of postganglionic MSNA were obtained from a muscle nerve fascicle in the peroneal nerve posterior to the fibular head in all subjects. This technique has been validated and extensively described in studies from our laboratory and elsewhere. 19, [22] [23] [24] [25] [26] [27] [28] In brief, recordings were obtained by percutaneous insertion of tungsten microelectrodes into the peroneal nerve. The electrodes were connected to a preamplifier and the nerve signal was fed through a bandpass filter and routed through an amplitude discriminator to a storage oscilloscope and loudspeaker. For recording and analysis, the filtered neurogram was fed through a resistance-capacitance integrating network to obtain a mean voltage display of the neural activity. Standard criteria for acceptance of a recording of MSNA were achieved in all subjects.19 '22-28 Resting nerve activity was measured for up to 10 minutes before the study was begun to ensure that a stable baseline of nerve activity had been obtained. Sympathetic bursts were identified by inspection of the mean voltage neurogram. Individual burst frequency was determined as bursts per minute.
Nerve activity was also corrected for heart rate and expressed as bursts per 100 heartbeats.19 Individual burst amplitude was measured and total integrated muscle sympathetic nerve activity was calculated as the total sum of burst amplitudes per minute and expressed as units per minute. Thus, sympathetic nerve activity was expressed in four ways: 1) bursts per minute, 2) total integrated nerve activity as units per minute, 3) heart rate-corrected activity as sympathetic bursts per 100 heartbeats, and 4) total activity corrected for heart rate and expressed as units per 100 heartbeats. Prior studies in our laboratory determined an intraobserver variability of 5% and an interobserver variability of less than 10% in this calculation of sympathetic nerve activity. 24 
Procedures
Orthostatic stress was simulated by the technique of LBNP using a chamber placed over the subject's body below the iliac crest.17,26,29-32 LBNP was applied for consecutive sequential 2-minute periods at levels of 0 (control), -5 dobutamine produced nearly identical responses in hemodynamic and MSNA parameters compared with Cedilanid-D. The only significant difference in effect on control parameters was a slight increase in heart rate during dobutamine infusion and a decrease in heart rate after Cedilanid-D. There was also a tendency for an increase in forearm vascular resistance after digitalis compared with dobutamine, but this did not achieve statistical significance. Intravenous administration of placebo had no statistically significant effect on resting hemodynamics or MSNA.
Effects of Digitalis on Responses to Cardiopulmonary Baroreceptor Deactivation (LBNP)
The hemodynamic and MSNA responses of subjects 1-8 during application of incremental levels of LBNP at 0 (control), -5, -10, and -15 mm Hg, before and after administration of Cedilanid-D, are summarized in '36 One of the earliest suggestions that digitalis exerts autonomic actions in humans was the observation by Mason and Braunwald16 that intravenous ouabain produces vasoconstriction in normal humans compared with vasodilation in patients with heart failure. Subsequently, numerous studies in patients with heart failure have suggested that this disorder is characterized by impairment of autonomic mechanisms, especially those involving the cardiopulmonary baroreflex.37 Prior studies in our laboratory using forearm blood flow responses as indirect indexes of neuroeffector responses during unloading of cardiopulmonary baroreceptors with LBNP indicated that patients with moderate to severe heart failure demonstrate impairment of forearm vasoconstrictor responses to orthostatic stress.17 These impaired cardiopulmonary baroreflex responses were acutely normalized after intravenous administration of clinical doses of a rapidly acting digitalis preparation. Similarly, intravenous administration of Cedilanid-D has been demonstrated to augment the sinoaortic baroreflex-mediated bradycardic and hypotensive response to arterial baroreceptor activation in normal and hypertensive human subjects. 18 Recently, studies in our laboratory directly examined resting hemodynamics and efferent MSNA in patients with moderate to severe heart failure before and after administration of Cedilanid-D. 19 Administration of this rapidly acting digitalis preparation produced an early, marked, and sustained inhibition of resting MSNA that preceded any observed hemodynamic effect of the agent and was accompanied by forearm vasodilation and a modest increase in cardiac output and decrease in cardiac filling pressures. However, in a separate but similar group of heart failure patients, administration of equal inotropic doses of dobutamine failed to alter MSNA, suggesting that the sympathoinhibitory action of digitalis was not due simply to its inotropic properties. The studies outlined in the present report were designed to further investigate the mechanism of action of digitalis in human subjects by directly examining cardiopulmonary baroreflex control of efferent sympathetic nerve activity.
Potential Mechanisms ofAction of Digitalis in Present Studies
Although mechanistic studies of autonomic reflex mechanisms in awake, intact human subjects have certain inherent limitations, the present studies were designed to evaluate possible mechanisms of action of digitalis on autonomic mechanisms in human subjects based on previous studies from our laboratory.'7'19 We considered the following as possible mechanisms for the observed actions of Cedilanid-D in the present studies: 1) activation of arterial baroreflex mechanisms resulting from increases in arterial pressure after administration of Cedilanid-D gener-alized, 2) nonspecific central nervous system potentiation of all sympathoexcitatory reflexes, 3) augmentation of cardiopulmonary baroreflex responses caused by mechanoreceptor stimulation by the inotropic action of digitalis, and 4) specific action of digitalis on afferent cardiopulmonary baroreflex pathways unrelated to the inotropic action of the agent.
In the present studies, we used three levels of LBNP (-5, -10, and -15 mmHg) to produce a graded decrease in cardiac filling pressures and thus a dose-dependent deactivation of cardiopulmonary baroreceptors. Observations were therefore determined over a range of alteration in cardiac filling pressures known to unload primarily the cardiopulmonary baroreceptors with little (if any) alteration in arterial pressure that would produce deactivation of arterial baroreceptors.17,2"26303138 As indicated in Tables 1 and 2 , we achieved the desired hemodynamic responses with LBNP before and after drug administration without altering the determinants of sinoaortic baroreceptor activity. These levels of LBNP produced a stimulus-dependent unloading of cardiopulmonary receptors (decrease in cardiac filling pressure) that was accompanied by a stimulusdependent increase in efferent MSNA (Tables 1 and  2 , Figure 3) . The results in the present study are comparable with those observed in prior human studies.26,38 Of particular note, the magnitude of the LBNP unloading was nearly identical in trials before and after administration of digitalis, dobutamine, and placebo. Thus, we believe these observations permit us to conclude that any observed actions of digitalis on responses to LBNP were not due to actions on arterial baroreflex pathways.
Animal studies suggest that digitalis glycosides may exert central neural actions although these effects are most commonly sympathoexcitatory in nature.510'1 As indicated in Table 1 , control (pre-LBNP) MSNA was significantly decreased after administration of Cedilanid-D. This is consistent with prior observations from our laboratory in patients with heart failure'9 and could result from sensitization of affer- Figure 1 , the hemodynamic responses to dobutamine were very similar to those observed after digitalis with the exception that digitalis produced an expected decrease in heart rate (direct vagal effect). The failure of dobutamine to potentiate cardiopulmonary baroreflex-mediated MSNA responses during LBNP argues that an inotropic effect alone cannot explain the actions of digitalis in the present studies. Similarly, previous studies from our laboratory demonstrated a marked sympathoinhibitory action of digitalis with no such effect after administration of dobutamine'9 in heart failure patients. Thus, we do not believe the potentiation of cardiopulmonary baroreflex responses observed after acute digitalization in the present studies are explained by the modest inotropic action of digitalis.
Although the levels of LBNP used in the present studies altered cardiac filling pressures (and thereby cardiopulmonary baroreceptor activity) without altering arterial pressures (and thereby arterial baroreceptors), we recognize the possibility that the altered responses to LBNP after digitalis might be due to effects of the agent on the determinants of arterial baroreflex activity and secondary alteration of cardiopulmonary and arterial baroreflex interactions. As shown in Table 1 and Figure 1 , administration of digitalis significantly increased resting arterial pressure parameters and decreased heart rate and MSNA. This would be consistent with an activation of sinoaortic baroreceptors via the increase in blood pressure and would be expected to inhibit efferent MSNA. The fact that we observed an augmentation of MSNA responses to LBNP after digitalis, even in the presence of presumed sinoaortic baroreflex-mediated sympathoinhibition, suggests that the potentiation of cardiopulmonary baroreflexes was of such a sufficient degree to override arterial baroreflex actions. In addition, despite similar effects of dobutamine on control blood pressure, we observed no such potentiation of cardiopulmonary baroreflexes after administration of this agent.
The observation that digitalis acutely augmented cardiopulmonary baroreflex control of MSNA whereas similar inotropic doses of dobutamine failed to exert such an effect suggests that the sympathetic potentiation does not result from an inotropic action of digitalis alone. As noted in Table 1 , Cedilanid-D produced a marked inhibition of control MSNA. This observation is consistent with prior studies from our laboratory in patients with heart failure'9 and would In the present study involving normal human suibjects, digitalis potentiated sympathetic neural responses to simulated orthostatic stress, whereas forearm vasoconstrictor responses were not altered (Table 1) . In contrast, a previous study from our laboratory in heart failure patients17 demonstrated that digitalis glycosides potentiated (thus tending to normalize) impaired forearm vasoconstrictor responses to similar levels of LBNP. This previous study did not have the benefit of simultaneous direct examination of sympathetic neural responses in heart failure patients. We believe that the apparent discrepancy between sympathetic neural and vascular responses in the present study of normal subjects and the prior finding of augmented vasoconstrictor responses to orthostatic stress in heart failure patients is most likely explained by differing actions of digitalis on baseline vascular resistance in these two different groups of human subjects.
In the present study, digitalis tended to increase baseline forearm vascular resistance of these normal subjects (Table 1) Thus, the present study provides important new observations in normal subjects by combining both direct (efferent sympathetic nerve activity) and indirect (forearm blood flow) assessments of sympathetically mediated responses to orthostatic stress. The indirect assessment by measuring forearm blood flow responses is limited by the potential direct vasoconstrictor action of digitalis on arterial smooth muscle, and such observations alone may obscure actual potentiation of baroreflex responses. However, the clear evidence of potentiated sympathetic neural responses to LBNP supports the hypothesis of digitalis-induced potentiation of cardiopulmonary baroreflex mechanisms in normal subjects. The present observations are therefore important in understanding reflex autonomic actions of digitalis that would have been missed had indirect vasoconstrictor responses alone been examined.
In our previous study of heart failure patients, digitalis resulted in a reduction in baseline vasoconstriction (vasodilation) in heart failure patients similar to that previously reported by Mason and Braunwald. 16 After digitalis administration, these heart failure patients exhibited a potentiated vasoconstrictor response to LBNP consistent with potentiation and normalization of impaired baroreflex responses.
Potential Limitations of Present Studies
We recognize several potential limitations in the design and interpretation of the present studies. First, these studies were acute in nature and do not necessarily predict long-term effects of digitalis glycosides in humans. However, recent studies in normal dogs suggest that long-term administration of digitalis produces a sustained potentiation of vagally mediated cardiopulmonary baroreflex inhibition of renal sympathetic activity. 35 Second, the present studies were performed in normal human subjects, and caution must be exercised in applying these observations to patients with clinical disorders in whom digitalis is used therapeutically. However, the sympathoinhibitory effects observed here are similar to those recently reported from our laboratory in patients with heart failure. 19 The present studies extend these earlier observations and suggest a definite mechanism of action of digitalis on the afferent limb of the cardiopulmonary baroreflex. Third, we have attempted to examine the cardiopulmonary baroreflex during maneuvers that deactivated these mechanoreceptors (LBNP). It is possible that other effects of digitalis would be observed under conditions of activation (loading) of such receptors. However, by examining efferent sympathetic responses over an extended and physiologically relevant range of cardiac filling pressures, we believe the current studies are functionally important. A fourth concern is that the techniques used in the present studies required observations to be made with the subjects in a supine position. It is possible that other effects would be observed in subjects studied in the upright position. In the performance of these studies, we used recordings of efferent sympathetic nerve activity from only one site, the peroneal nerve. It is known that there are important differences in the control of sympathetic nerve activity to 
Potential Clinical Implications
Digitalis glycosides are important therapeutic agents in the treatment of patients with heart failure. This clinical disorder is known to be associated with abnormalities of cardiopulmonary baroreflex control mechanisms.37 Although digitalis appears to be a modest inotropic agent in such patients when administered orally, recent studies from our laboratory suggest that this agent may also acutely exert a sympathoinhibitory action in these patients. 19 The present study provides strong evidence that the mechanism of this effect in humans relates to actions of digitalis on afferent cardiopulmonary baroreflex mechanisms.
